Cytokinetics, Inc. (CYTK) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $64.80 -3.02%
Revenue Growth %: -77.2%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -77.2%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.82 million versus the consensus estimate of $1.06 million.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) tops Q1 EPS by 3c; misses on guidance
- Western Digital (WDC) Misses Q3 EPS by 21c; offers guidance
- T-Mobile posts mixed Q1 top and bottom line, expects more subscribers in 2024
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
